# CVS says GLP-1s save money when priced below $350 per month

- URL: https://talkfuse.com/story/cvs-says-glp-1s-save-money-when-priced-below-350-per-month/
- Published: 2026-11-15T17:43:49+00:00
- Updated: 2026-11-15T18:28:22+00:00
- Original publisher: New York Post (publisher lean: Right)
- Original article: https://nypost.com/2026/11/15/business/cvs-says-glp-1s-save-money-when-priced-below-350-per-month/
- Topics: Health, Medicine, World

## Key points

- CVS estimates GLP-1s need to cost below $350 monthly for plans to break even.
- Three-year medical savings were outweighed by higher prescription spending.
- Patients at higher risk may generate savings sooner.

## Summary

CVS Health says health plans could break even on GLP-1 medicines if their price fell below $350 a month, because reduced use of medical services could offset prescription spending. Its analysis found that at current prices, the medicines still raise overall costs, a finding relevant as employers weigh whether to cover them amid rising premiums.

The analysis compared new users of medicines including Ozempic, Mounjaro, Wegovy and Zepbound with similar non-users, using claims data from 2023 to 2025. GLP-1 use was associated with 10% to 12% fewer emergency visits in the first two years; among 4,000 people still taking the drugs after three years, hospitalisations fell by 34% to 42%. Over three years, plans saved $9,400 per person on medical bills but spent $13,300 more on prescriptions, a net increase of $3,900; savings varied with patients’ health risks.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.